NCT02758353View on ClinicalTrials.gov

The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria

NACompletedINTERVENTIONAL
Enrollment

31,493

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
MalariaStillbirths
Interventions
DRUG

Community distribution of SP

SP delivered at both the community and facility level by trained CBHVs in three LGAs.

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Federal Ministry of Health, Nigeria

OTHER_GOV

lead

JSI Research & Training Institute, Inc.

OTHER

NCT02758353 - The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria | Biotech Hunter | Biotech Hunter